Catherine Caruso is a freelance science journalist based in Boston, Massachusetts. Her work has appeared in Scientific American, MIT Technology Review and Hakai Magazine. She has a master’s degree in zoology from the University of New Hampshire and a master’s degree in science writing from the Massachusetts Institute of Technology.
Catherine Caruso
From this contributor
Diagnostic odyssey; breaking through; leading role
A doctor decodes a rare genetic condition, burnout is a big problem in science, and an actor with autism will play the lead in “The Curious Incident of the Dog in the Night-Time.”
Diagnostic odyssey; breaking through; leading role
By
Catherine Caruso
19 May 2017 | 5 min read
Collaborative conference; drug danger; autism map
Autism researchers and advocates gather in San Francisco, nearly one-third of drugs approved in the United States are later linked to safety issues, and an interactive map lays out locations of U.S. autism clinics.
Collaborative conference; drug danger; autism map
By
Catherine Caruso
12 May 2017 | 4 min read
Network television; facing forward; warm welcome
Researchers captured networks of neurons lighting up in a small aquatic animal, facial recognition software can flag genetic conditions, and a Muppet with autism makes her debut on “Sesame Street.”
Network television; facing forward; warm welcome
By
Catherine Caruso
14 April 2017 | 4 min read
Funding free fall; mending mutations; film focus
Donald Trump’s budget blueprint calls for considerable cuts to science agencies, CRISPR corrects mutations in human embryos, and a documentary highlights the challenges faced by an adult with autism.
Funding free fall; mending mutations; film focus
By
Catherine Caruso
17 March 2017 | 4 min read
Behavior boost; double data; common interests
Neuroscientists should not forget that brains have owners, a new genetic database makes its debut, and the intense interests of people with autism offer opportunities.
Behavior boost; double data; common interests
By
Katie Moisse, Catherine Caruso
3 March 2017 | 4 min read
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read